Home > Financial Ratios > LASA SUPERGENERICS

LASA SUPERGENERICS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for LASA SUPERGENERICS
Please provide your vote to see the results

LASA SUPERGENERICS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 148.85-129.21-65.6056.89160.58

What is the latest Core EBITDA Growth ratio of LASA SUPERGENERICS ?

The latest Core EBITDA Growth ratio of LASA SUPERGENERICS is 148.85 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar2024148.85
Mar2023-129.21
Mar2022-65.60
Mar202156.89
Mar2020160.58

How is Core EBITDA Growth of LASA SUPERGENERICS Trending?

Years Core EBITDA Growth % Change
Mar2024 148.85
Positive
Mar2023 -129.21
Negative
Mar2022 -65.6
Negative
Mar2021 56.89
-64.57
Mar2020 160.58 -

Other Financial Ratios of LASA SUPERGENERICS


Compare Core EBITDA Growth ratio of peers of LASA SUPERGENERICS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LASA SUPERGENERICS ₹38.1 Cr -3.6% -15.4% -65.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,777.0 Cr -0.1% 4.7% 6.2% Stock Analytics
DIVIS LABORATORIES ₹168,931.0 Cr -1.7% 2.5% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹147,330.0 Cr -1.1% 7.6% 45.4% Stock Analytics
DR REDDYS LABORATORIES ₹109,593.0 Cr -0.4% 6.3% 14.7% Stock Analytics
CIPLA ₹107,112.0 Cr -2.3% 0.3% -8.9% Stock Analytics


LASA SUPERGENERICS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LASA SUPERGENERICS

-3.6%

-15.4%

-65.1%

SENSEX

-2.8%

-2%

7.3%


You may also like the below Video Courses